Abstract:Mutations of the MEN1 gene lead to the occurrence of multiple endocrine neoplasia type 1 (MEN1). To gain insights into the mechanisms of the tumorigenesis related to MEN1 inactivation, we have used mice in which the Men1 gene was specifically disrupted in pancreatic beta-cells. In these mice, we observed full penetrance of insulinoma with defined histological characteristics of tumorigenesis. To identify the genetic factors taking part in the tumour development, we performed gene expression profiling analysis of these insulinomas at different stages. Here, we show that in late stage insulinomas, 56 genes are up-regulated and 194 are down-regulated more than fourfold compared with normal pancreatic islets. Clustering analysis reveals the deregulation of Hox gene family and the genes involved in cell proliferation and cell cycle control. The altered expression of Igf2, Igfbp3 and Igfbp6 as well as cyclin A2, B2 and D2 are confirmed by quantitative RT-PCR, with the overexpression of all the three cyclins found in early stage insulinomas. Moreover, an increased proportion of cyclin A2- and D2-expressing cells and the overexpression of insulin-like growth factor 2 (IGF2) protein are detected in mouse Men1 insulinomas by immunostaining. Interestingly, the analysis of DNA methylation patterns by quantitative serial pyrosequencing reveals that four specific CpGs in the intragenic differentially methylated region 2 (DMR2) region of the Igf2 gene known to augment transcription through methylation are significantly hypermethylated in insulinomas of Men1 beta-cell mutant mice at 6 and 10 months of age, even before IGF2 overexpression can be detected. Thus, our data indicate the involvement of both genetic and epigenetic mechanisms in early tumorigenesis of beta-cells related to MEN1 inactivation.

Tumour Suppressor Menin is Essential for Development of the Pancreatic Endocrine Cells

Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.

Pancreatic Beta-Cell-Specific Ablation Of The Multiple Endocrine Neoplasia Type 1 (Men1) Gene Causes Full Penetrance Of Insulinoma Development In Mice

Men1 Maintains Exocrine Pancreas Homeostasis in Response to Inflammation and Oncogenic Stress.

Conditional deletion of Men1 in the pancreatic β-cell leads to glucagon-expressing tumor development.

Differentially expressed genes in Men1 knockout and wild‑type embryoid bodies for pancreatic islet development.

Characterisation of Prostate Cancer Lesions in Heterozygous Men1 Mutant Mice

Menin Epigenetically Represses Hedgehog Signaling in Men1 Tumor Syndrome

Functional Interaction Between Tumor Suppressor Menin And Activator Of S-Phase Kinase

Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.

Heterozygous<i>Men1</i>Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1

MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer

Gene Expression Profiling in Insulinomas of Men1 Beta-Cell Mutant Mice Reveals Early Genetic and Epigenetic Events Involved in Pancreatic Beta-Cell Tumorigenesis.

Glucose-mediated Repression of Menin Promotes Pancreatic Β-Cell Proliferation.

Menin in Cancer

Supplementary Figures 1-7 from Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome

Beclin1 is essential for the pancreas development

Targeting Β-Catenin Signaling for Therapeutic Intervention in MEN1-deficient Pancreatic Neuroendocrine Tumours

Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.

Progress on Biological Function of MEN 1 Gene